Research advances hunt for a safe and effective preventative HIV vaccine.
HIV
Latest News
Advertisement
CME Content
Advertisement
HIV continues to be a global problem, and researchers from Brazil have joined the growing chorus of voices in emphasizing that pharmacist involvement in care for patients with HIV improves outcomes.
Scientists say ring containing pre-exposure prophylaxis and Truvada is safe in US teens, now need data in African adolescent girls.
New cases of HIV in Swaizland down 50% between 2011 and 2016.
The label has been updated to include data from adults co-infected with hepatitis C virus and HIV-1.
Providing gift cards observed to increase viral suppression among HIV-positive patients.
Top news of the day from across the health care landscape.
Increased efforts in prevention and treatment for HIV show promise in high-burden regions.
Dicovery could lead to more effective treatments for influenza, rhinovirus, and HIV.
More than half of survey respondents with HIV reported concerns about possible drug-drug interactions.
Long-acting HIV medications could solve problems with adherence, reduce costly laboratory tests to monitor their efficacy, and bring down drug costs.
Top articles of the week from Specialty Pharmacy Times.
HIV patients lack crucial peroxisomal proteins in the brain.
Prequalification will allow countries to access generic sofosbuvir and an HIV self-test.
Response rate higher among patients with HIV treated with dolutegravir compared with lopinavir/ritonavir.
Top news of the day from across the health care landscape.
Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.
The future for pharmacy is very lucrative as they press on for provider status.
Resistance poses a global threat.
Fixed-dose combination tablet containing doravirine achieved viral suppression in HIV-1 infected treatment-naïve adults.
Immunization of cows induces rapid elicitation of broadly neutralizing antibodies to HIV.
Gilead's experimental combination therapy observed to reduce HIV RNA in adult patients.
Top news of the day from across the health care landscape.
The demand for innovation is not slowing down.
Combination treatments well tolerated amongst study participants with HIV-1 infection.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief
2
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
3
Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds
4
The Weekly Dose: AHA Says Coffee Is Safe for Most, Wildfire Smoke Risks for Respiratory Patients, and New Options for Sleep Apnea, ROS1-Positive Lung Cancer
5